TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/3/26 16:23 | 2/1/26 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goldstein Dov A Md | CA | O | CFO | M.d | 16 | 4.38 | 0 | 4 | 14 | 29 | D | ||||||||||||||
1/21/26 16:20 | 1/16/26 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goldstein Dov A Md | CA | O | CFO | M.d | 16 | 4.38 | 0 | 4 | 16 | 26 | D | ||||||||||||||
1/15/26 16:22 | 1/13/26 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goldstein Dov A Md | CA | O | CFO | M.d | 227 | 8.39 | 0 | 27 | 22 | D | |||||||||||||||
1/15/26 16:22 | 1/13/26 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goldstein Dov A Md | CA | O | CFO | S.d | -532 | 19.70 | 0 | -27 | -55 | 22 | D | ||||||||||||||
8/19/25 16:01 | 8/18/25 | COYA | Coya Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goldstein Dov A Md | TX | D | M.d | 19 | 1.09 | 0 | 18 | 176 | 28 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |